FRPT Freshpet (FRPT) Insider Trading, Ownership & Congress Trades
Food & Beverage · Grain mill products · CIK 0001611647
Cluster · 6 insidersForm 144 · 18
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
166
13F, latest reported quarter
Conversions, 180 days
48
Codes C/M, not in net · $10.2M priced
What the filings say about FRPT
Insiders, 180 days
-$32.7M net sold
6 buyers · 1 seller · 28% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$19.1M
18 notices
Freshpet insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Freshpet, Inc. insiders sold a net $32.7M of stock across 143 Form 4 purchases and sales, with 6 insiders buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 8 earlier Form 4 trades (code P or S) here by this insider (8 buys), the last on May 8, 2026.
- -9.6% median (-7.9% mean) 90-day return after 8 previous buys.
- The trade is 1.9% of the 51,746 shares held after it.
- No other insider bought within 30 days.
- 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director GEORGE WALTER N. bought about $64.9K of FRPT on Sep 14, 2026; 166 funds added in the latest 13F quarter.Context
- 58 earlier Form 4 trades (code P or S) here by this insider (1 buy, 57 sales), the last on Aug 24, 2026.
- The trade is 10.6% of the 350,744 shares held after it.
- No other insider sold within 30 days.
- 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Cyr William B. sold about $2.8M of FRPT under a 10b5-1 plan on Aug 26, 2026; 166 funds added in the latest 13F quarter.Context
- 58 earlier Form 4 trades (code P or S) here by this insider (1 buy, 57 sales), the last on Aug 24, 2026.
- The trade is 1.2% of the 49,044 shares held after it.
- No other insider sold within 30 days.
- 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Cyr William B. sold about $42.8K of FRPT under a 10b5-1 plan on Aug 26, 2026; 166 funds added in the latest 13F quarter.Context
- 58 earlier Form 4 trades (code P or S) here by this insider (1 buy, 57 sales), the last on Aug 24, 2026.
- The trade is 1.0% of the 106,530 shares held after it.
- No other insider sold within 30 days.
- 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Cyr William B. sold about $83.7K of FRPT under a 10b5-1 plan on Aug 26, 2026; 166 funds added in the latest 13F quarter.Context
- 58 earlier Form 4 trades (code P or S) here by this insider (1 buy, 57 sales), the last on Aug 24, 2026.
- The trade is 1.0% of the 96,677 shares held after it.
- No other insider sold within 30 days.
- 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Cyr William B. sold about $73.8K of FRPT under a 10b5-1 plan on Aug 26, 2026; 166 funds added in the latest 13F quarter.143 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$32.7M over 180 days
-$19.2M over 90 days
below 89% of Food & Beverage
Congress
no House purchase disclosed in the last 12 months
Funds
166 funds bought in last quarter
more than 55% of Food & Beverage
Revenue
+13.0% year over year
more than 75% of Food & Beverage
Margin
12.6% net margin
more than 87% of Food & Beverage
Buybacks
$54.4M repurchased, FY to 2026-06-30
more than 54% of Food & Beverage
Short interest
17.3% of the float short (float per yahoo 2026-10-26) · 7.8 days to cover · settled 2026-09-30
more than 95% of Food & Beverage
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch FRPT
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+11.5%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns FRPT: institutional holders (13F)
13F holdings, latest reported quarter
5,886,208 sh
$348.0M
3,044,165 sh
$180.0M
2,936,578 sh
$173.6M
2,829,688 sh
$167.3M
2,819,293 sh
$166.7M
Congress trades in FRPT
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
FRPT planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Cyr William B.
Filed 2026-08-26
$126.5K
Cyr William B.
Filed 2026-08-26
$73.8K
Cyr William B.
Filed 2026-08-26
$2.8M
Cyr William B.
Filed 2026-08-24
$81.8K
Cyr William B.
Filed 2026-08-24
$139.9K
FRPT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
ProShares Pet Care ETF
$3.2M position · as of 2026-05-31
9.8%
Invesco S&P SmallCap Consumer Staples ETF
$1.8M position · as of 2026-05-31
5.3%
First Trust Consumer Staples AlphaDEX Fund
$9.4M position · as of 2026-07-31
4.1%
Wasatch Ultra Growth Fund
$16.7M position · as of 2026-06-30
3.6%
Invesco Food & Beverage ETF
$3.5M position · as of 2026-07-31
3.2%
Royce Smaller-Companies Growth Fund
$4.9M position · as of 2026-06-30
2.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Cyr
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2022
$914.9K
-$4.1M
$980.2K
-11%
+19%
2021
$765.0K
-$9.5M
$522.7K
+61%
+77%
2020
$15.9M
$32.2M
$8.0M
+140%
+45%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
6 insiders reported buying shares.
The record shows a net $32.7M sold by insiders over 180 days, 166 funds added last quarter, $19.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
FRPT financials
Revenue growth
+13.0%
XBRL, annual
Net margin
12.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM FRPT
| FY Dec 2025 | $1.1B |
| FY Dec 2024 | $975.2M |
| FY Dec 2023 | $766.9M |
| FY Dec 2022 | $595.3M |
| FY Dec 2021 | $425.5M |
| Jun 2026 | $305.6M |
| Mar 2026 | $297.6M |
| Dec 2025 | $285.2M |
| Sep 2025 | $288.8M |
| Jun 2025 | $264.7M |
| Mar 2025 | $263.2M |
| Dec 2024 | $262.7M |
| Sep 2024 | $253.4M |
At each fiscal year end
Single quarter
Net margin, TTM
+17.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM FRPT
| FY Dec 2025 | +12.6% |
| FY Dec 2024 | +4.8% |
| FY Dec 2023 | -4.4% |
| FY Dec 2022 | -10.0% |
| FY Dec 2021 | -7.0% |
| Jun 2026 | +6.4% |
| Mar 2026 | +16.3% |
| Dec 2025 | +11.9% |
| Sep 2025 | +35.2% |
| Jun 2025 | +6.2% |
| Mar 2025 | -4.8% |
| Dec 2024 | +6.9% |
| Sep 2024 | +4.7% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$61.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM FRPT
| FY Dec 2025 | $12.4M |
| FY Dec 2024 | -$32.8M |
| FY Dec 2023 | -$163.2M |
| FY Dec 2022 | -$273.3M |
| FY Dec 2021 | -$321.5M |
| Jun 2026 | $14.7M |
| Mar 2026 | $12.7M |
| Dec 2025 | $2.1M |
| Sep 2025 | $31.6M |
| Jun 2025 | $445.0K |
| Mar 2025 | -$21.7M |
| Dec 2024 | -$7.9M |
| Sep 2024 | $22.1M |
At each fiscal year end
Single quarter
Debt to equity
0.38x
long-term 2026-06-30 plus current 2022-09-30 (45 months older than the period end); equity 2026-06-30
Debt to equity FRPT
| FY Dec 2025 | 0.39x |
| FY Dec 2024 | 0.44x |
| FY Dec 2023 | 0.49x |
| FY Dec 2022 | 0.07x |
| FY Dec 2021 | 0.00x |
| Jun 2026 | 0.38x |
| Mar 2026 | 0.37x |
| Dec 2025 | 0.39x |
| Sep 2025 | 0.40x |
| Jun 2025 | 0.44x |
| Mar 2025 | 0.45x |
| Dec 2024 | 0.44x |
| Sep 2024 | 0.46x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.44x
TTM operating cash flow over long-term 2026-06-30 plus current 2022-09-30 (45 months older than the period end)
Cash flow to debt FRPT
| FY Dec 2025 | 0.34x |
| FY Dec 2024 | 0.33x |
| FY Dec 2023 | 0.16x |
| FY Dec 2022 | -0.59x |
| FY Dec 2021 | n/a |
| Jun 2026 | 0.44x |
| Mar 2026 | 0.42x |
| Dec 2025 | 0.34x |
| Sep 2025 | 0.33x |
| Jun 2025 | 0.31x |
| Mar 2025 | 0.33x |
| Dec 2024 | 0.33x |
| Sep 2024 | 0.30x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+17.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity FRPT
| FY Dec 2025 | +12.3% |
| FY Dec 2024 | +4.7% |
| FY Dec 2023 | -3.4% |
| FY Dec 2022 | -6.8% |
| FY Dec 2021 | -5.3% |
| Jun 2026 | +17.6% |
| Mar 2026 | +17.3% |
| Dec 2025 | +12.3% |
| Sep 2025 | +11.2% |
| Jun 2025 | +3.3% |
| Mar 2025 | +1.5% |
| Dec 2024 | +4.7% |
| Sep 2024 | +4.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+11.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets FRPT
| FY Dec 2025 | +8.3% |
| FY Dec 2024 | +3.1% |
| FY Dec 2023 | -2.6% |
| FY Dec 2022 | -6.2% |
| FY Dec 2021 | -4.9% |
| Jun 2026 | +11.8% |
| Mar 2026 | +11.8% |
| Dec 2025 | +8.3% |
| Sep 2025 | +7.5% |
| Jun 2025 | +2.1% |
| Mar 2025 | +1.0% |
| Dec 2024 | +3.1% |
| Sep 2024 | +3.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate -29%, not meaningful
Return on invested capital FRPT
| FY Dec 2025 | n/a |
| FY Dec 2024 | +3.2% |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | +2.9% |
| Mar 2025 | +1.4% |
| Dec 2024 | +3.2% |
| Sep 2024 | +2.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+5.8%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed FRPT
| FY Dec 2025 | +4.8% |
| FY Dec 2024 | +2.7% |
| FY Dec 2023 | -2.5% |
| FY Dec 2022 | -5.9% |
| FY Dec 2021 | -4.4% |
| Jun 2026 | +5.8% |
| Mar 2026 | +5.7% |
| Dec 2025 | +4.8% |
| Sep 2025 | +3.3% |
| Jun 2025 | +2.5% |
| Mar 2025 | +1.3% |
| Dec 2024 | +2.7% |
| Sep 2024 | +2.4% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
16.87x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing FRPT
| FY Dec 2025 | 23.71x |
| FY Dec 2024 | 157.56x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 15.56x |
| Mar 2026 | 15.76x |
| Dec 2025 | 23.71x |
| Sep 2025 | 24.07x |
| Jun 2025 | 101.43x |
| Mar 2025 | 268.29x |
| Dec 2024 | 157.56x |
| Sep 2024 | 151.97x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$3.2B
market value at close 2026-10-23 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2022-09-30 (45 months older than the period end), minus cash 2026-06-30
Enterprise value FRPT
| FY Dec 2025 | $3.2B |
| FY Dec 2024 | $7.4B |
| FY Dec 2023 | $4.4B |
| FY Dec 2022 | $2.5B |
| FY Dec 2021 | $4.1B |
| Jun 2026 | $3.0B |
| Mar 2026 | $3.0B |
| Dec 2025 | $3.2B |
| Sep 2025 | $2.9B |
| Jun 2025 | $3.5B |
| Mar 2025 | $4.3B |
| Dec 2024 | $7.4B |
| Sep 2024 | $6.8B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.0%
TTM free cash flow over market value at close 2026-10-23
FCF yield FRPT
| FY Dec 2025 | +0.4% |
| FY Dec 2024 | -0.5% |
| FY Dec 2023 | -3.9% |
| FY Dec 2022 | -10.8% |
| FY Dec 2021 | -7.8% |
| Jun 2026 | +2.1% |
| Mar 2026 | +1.6% |
| Dec 2025 | +0.4% |
| Sep 2025 | +0.1% |
| Jun 2025 | -0.2% |
| Mar 2025 | -0.3% |
| Dec 2024 | -0.5% |
| Sep 2024 | -1.0% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.04x
P/E over trailing EPS growth of 467%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing FRPT
| FY Dec 2025 | 0.14x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 0.03x |
| Mar 2026 | 0.01x |
| Dec 2025 | 0.14x |
| Sep 2025 | 0.16x |
| Jun 2025 | 3.23x |
| Mar 2025 | 4.25x |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $1.1B | $975.2M | $766.9M | $595.3M |
| Gross profit | $449.6M | $396.0M | $250.9M | $186.0M |
| Operating income | $75.7M | $38.0M | -$30.4M | -$52.0M |
| Net income | $139.1M | $46.9M | -$33.6M | -$59.5M |
| EPS (diluted) | 2.64 | 0.93 | -0.70 | -1.29 |
| Operating cash flow | $160.6M | $154.3M | $75.9M | -$43.2M |
| Cash | $278.0M | $268.6M | $296.9M | $132.7M |
| Long-term debt | $397.3M | $395.2M | $393.1M | $0 |
SEC XBRL, fiscal years, as known on 2026-10-27
FRPT Stock Sonar score 6/7 axes
Find similar shapesCompareFRPT ranks highest on profitability (75th percentile) and growth (75th), and lowest on institutional and government (55th), among Food & Beverage peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
FRPT filings, in plain words
Are Freshpet insiders buying or selling FRPT?
In the 180 days to 2026-10-27, Freshpet insiders were net sellers, a net $32.7M: $523.1K of purchases and $33.2M of sales reported on Form 4, by 6 buyers and 1 seller.
Are there planned insider sales of FRPT?
Yes. 18 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $19.1M of stock; the latest, by Cyr William B., was filed 2026-08-26.
Read the full summary
In the 180 days to 2026-10-27, Freshpet insiders were net sellers of FRPT, a net $32.7M across purchases and sales reported on Form 4 by 6 buyers and 1 seller. Sales outweighed purchases more than tenfold by value. 6 insiders reported purchases in that window. 28% of the 61 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 18 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $19.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
